Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 30Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 20Papillomavirus Vaccines 9Radiotherapy, Intensity-Modulated 4Cisplatin 4Blood Specimen Collection 4fludarabine 3Vaccines, Synthetic 3Engerix-B 3Cyclophosphamide 3halofantrine 2fludarabine phosphate 2aldesleukin 2Watchful Waiting 2Vaccines 2Patient Navigation 2Paclitaxel 2Light Coagulation 2Interleukin-2 2Imiquimod 2Human Papillomavirus Recombinant Vaccine nonavalent 2Hepatitis A Vaccines 2Fluorouracil 2Electrocoagulation 2Cetuximab 2Carboplatin 2Albumin-Bound Paclitaxel 2utomilumab 1polyphenon E 1infigratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Papillomavirus Infections × Electrocoagulation × Clear all
NCT04092257 2025-08-06

HPV-Based Screen-and-Treat Demonstration Project in Lilongwe

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
1,250 enrolled 12 charts
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT04191967 2023-01-25

Thermocoagulation for Treatment of Precancerous Cervical Lesions

University of California, San Francisco

Phase NA Completed
379 enrolled 10 charts

Acquired Immunodeficiency Syndrome, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡